Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD
dc.contributor.author | Konopka, Kristine E | |
dc.contributor.author | Nguyen, Teresa | |
dc.contributor.author | Jentzen, Jeffrey M | |
dc.contributor.author | Rayes, Omar | |
dc.contributor.author | Schmidt, Carl J | |
dc.contributor.author | Wilson, Allecia M | |
dc.contributor.author | Farver, Carol F | |
dc.contributor.author | Myers, Jeffrey L | |
dc.date.accessioned | 2020-10-01T23:29:15Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-10-01T23:29:15Z | |
dc.date.issued | 2020-10 | |
dc.identifier.citation | Konopka, Kristine E; Nguyen, Teresa; Jentzen, Jeffrey M; Rayes, Omar; Schmidt, Carl J; Wilson, Allecia M; Farver, Carol F; Myers, Jeffrey L (2020). "Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD." Histopathology 77(4): 570-578. | |
dc.identifier.issn | 0309-0167 | |
dc.identifier.issn | 1365-2559 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/162704 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | autopsy | |
dc.subject.other | COVID | |
dc.subject.other | diffuse alveolar damage | |
dc.title | Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/162704/2/his14180.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/162704/1/his14180_am.pdf | en_US |
dc.identifier.doi | 10.1111/his.14180 | |
dc.identifier.source | Histopathology | |
dc.identifier.citedreference | de Lusignan S, Dorward J, Correa A et al. Risk factors for SARS‐CoV‐2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre Primary Care Network: a cross‐sectional study. Lancet Infect. Dis. 2020; 20; 1034 – 1042. | |
dc.identifier.citedreference | Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid‐19. N. Engl. J. Med. 2020; 383; 120 – 128. | |
dc.identifier.citedreference | Bos LD, Paulus F, Vlaar AP, Beenen LF, Schultz MJ. Subphenotyping ARDS in COVID‐19 patients: consequences of ventilator management. Ann. Am. Thorac. Soc. 2020. | |
dc.identifier.citedreference | Marini JJ, Gattinoni L. Management of COVID‐19 Respiratory Distress. JAMA 2020; 323; 2329. | |
dc.identifier.citedreference | Li X, Ma X. Acute respiratory failure in COVID‐19: is it ‘typical’ ARDS? Crit. Care 2020; 24; 198. | |
dc.identifier.citedreference | Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vender Heide RS. Pulmonary and cardiac pathology in African American patients with COVID‐19: an autopsy series from New Orleans. Lancet Respir. Med. 2020; 8; 681 – 686. | |
dc.identifier.citedreference | Lax SF, Skok K, Zechner P et al. Pulmonary arterial thrombosis in COVID‐19 with fatal outcome: results from a prospective, single‐center, clinicopathologic case series. Ann. Intern. Med. 2020. | |
dc.identifier.citedreference | Menter T, Haslbauer JD, Nienhold R et al. Post‐mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology 2020. | |
dc.identifier.citedreference | Tian S, Xiong Y, Liu H et al. Pathological study of the 2019 novel coronavirus disease (COVID‐19) through postmortem core biopsies. Mod. Pathol 2020; 33; 1007 – 1014. | |
dc.identifier.citedreference | Varga Z, Flammer AJ, Steiger P et al. Endothelial cell infection and endotheliitis in COVID‐19. Lancet 2020; 395; 1417 – 1418. | |
dc.identifier.citedreference | Instructions for completing the human infection with 2019 novel coronavirus (COVID‐19) case report form. Version 1, May 2020. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/2019‐ncov/downloads/COVID‐19‐Persons‐Under‐Investigation‐and‐Case‐Report‐Form‐Instructions.pdf (accessed 1 June 2020). | |
dc.identifier.citedreference | Konopka KE, Wilson A, Myers JL. Postmortem lung findings in an asthmatic patient with coronavirus disease 2019. Chest 2020. | |
dc.identifier.citedreference | Holshue ML, DeBolt C, Lindquist S et al. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020; 382; 929 – 936. | |
dc.identifier.citedreference | CDC COVID‐19 Response Team. Preliminary estimates of the prevalence of selected health conditions among patients with coronavirus disease 2019—United States, February 12‐March 28, 2020. Morb. Mortal. Wkly. Rep. 2020; 69; 382 – 386. | |
dc.identifier.citedreference | Schaller T, Hirschbühl K, Burkhardt K et al. Postmortem examination of patients with COVID‐19. JAMA 2020; 323; 2518 – 2520. | |
dc.identifier.citedreference | Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID‐19 autopsies, Oklahoma. USA. Am. J. Clin. Pathol. 2020; 153; 725 – 733. | |
dc.identifier.citedreference | Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early‐phase 2019 novel coronavirus (COVID‐19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. 2020; 15; 700 – 704. | |
dc.identifier.citedreference | Katzenstein AL, Bloor CM, Leibow AA. Diffuse alveolar damage—the role of oxygen, shock, and related factors. A review. Am. J. Pathol. 1976; 85; 209 – 228. | |
dc.identifier.citedreference | Ishiguro T, Kobayashi Y, Ryuji U et al. Viral pneumonia requiring differentiation from acute and progressive diffuse interstitial lung disease. Intern. Med. 2019; 58; 3509 – 3519. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.